Device Trial Radar · NCT04811235
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Sep 24, 2022
Primary completion
Oct 26, 2022
Study completion Apr 1, 2026
Sponsor
- Lead sponsor
- University of British ColumbiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- United States Department of Defense; Congressionally Directed Medical Research Programs
- First posted
- Mar 23, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- No
- Who can join
- All sexes, from 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study involves the 'first-in-human' evaluation of a novel optical sensor which uses near-infrared spectroscopy (NIRS) technology to assess oxygenation and hemodynamics of the injured spinal cord. The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time. Our testing of this novel NIRS sensor in patients with acute SCI represents the first step in translating this technology for human use.
Conditions
- Acute Spinal Cord Injury
- Spinal Cord Injuries
Interventions
Near Infra-Red Spectroscopy (NIRS) SensorDevice
The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Feasibility Assessment - OverallTime frame: Day 7
- Feasibility Assessment: Sensor ApplicationTime frame: Day 1
- Feasibility Assessment: Sensor RemovalTime frame: Day 7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vancouver General Hospital
Vancouver, British Columbia, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.